Flag of the European Union EU Clinical Trials Register Help

Clinical trials for KOH test

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    46 result(s) found for: KOH test. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2011-003087-70 Sponsor Protocol Number: PM1125 Start Date*: 2011-12-02
    Sponsor Name:Polichem SA
    Full Title: Randomized, open-label, controlled study on the efficacy of Ciclopoli® (ciclopirox 8% nail lacquer) versus Loceryl® (amorolfine 5% nail lacquer) on the culture conversion to negative in patients w...
    Medical condition: distal subungual onychomycosis without lunula involvement due to fungal nail pathogens (dermatophytes, white yeasts and/or Scopulariopsis spp. and/or Fusarium spp.) affecting at least one big toenail
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2013-005595-17 Sponsor Protocol Number: PMPed-004 Start Date*: 2014-02-11
    Sponsor Name:Polichem S.A.
    Full Title: Multicentre, open label study to assess the tolerability of P-3058 nail solution in paediatric patients affected by mild-to-moderate onychomycosis
    Medical condition: Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    16.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed) DE (Completed) BE (Completed) LV (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2012-003722-24 Sponsor Protocol Number: MOB015B-II Start Date*: 2012-10-17
    Sponsor Name:Moberg Derma AB
    Full Title: An open, single-centre pilot study of efficacy and safety of topical MOB015B in the treatment of distal subungual onychomycosis (DSO)
    Medical condition: Distal subungual onychomycosis (DSO)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-006513-33 Sponsor Protocol Number: KETFUN3001 Start Date*: 2007-05-23
    Sponsor Name:Janssen Pharmaceutica NV
    Full Title: A double-blind, randomized, parallel group comparison of Nizoral® cream (F012), ketoconazole 2% cream (F126) and placebo (F000) in the treatment of interdigital Tinea Pedis.
    Medical condition: For the treatment of tinea pedis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-004852-11 Sponsor Protocol Number: BT0400-207-INT Start Date*: 2006-02-07
    Sponsor Name:Barrier Therapeutics Inc.
    Full Title: A double-blind, randomized, placebo-controlled, dose finding study of R126638 given as a single or repeat dose in oral solution vs placebo in the treatment of pityriasis versicolor.
    Medical condition: Pityriasis versicolor / Tinea versicolor
    Disease: Version SOC Term Classification Code Term Level
    8.1 10056227 Pityriasis versicolour LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-001204-39 Sponsor Protocol Number: MOB015B-III Start Date*: 2016-09-15
    Sponsor Name:Moberg Pharma AB (publ)
    Full Title: A multi-centre, randomized, two-armed, parallel group and evaluator-blinded study of efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO)
    Medical condition: Distal Subungual Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) PL (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2022-001797-59 Sponsor Protocol Number: MOB015B-44-21-002 Start Date*: 2023-06-12
    Sponsor Name:Moberg Pharma AB
    Full Title: A multi-center, single-arm, open-label study to evaluate tolerability, safety, and efficacy of topical MOB015B solution in the treatment of mild to moderate distal subungual onychomycosis (DSO) in ...
    Medical condition: Distal Subungual Onychomycosis
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Trial now transitioned) DK (Trial now transitioned) PL (Trial now transitioned) IS (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2008-002707-10 Sponsor Protocol Number: PM0731 Start Date*: 2009-03-04
    Sponsor Name:Polichem SA
    Full Title: MULTICENTRE, RANDOMIZED, DOUBLE BLIND WITHIN FREQUENCY OF ADMINISTRATION, PLACEBO CONTROLLED, DOSE-FINDING, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF 3 DOSES OF P-3058 NAIL LACQUER (5% o.d., 10%...
    Medical condition: Mild to moderate distal subungual Onychomycosis due to Dermatophytes.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) LV (Completed) IT (Completed) FR (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2006-006338-17 Sponsor Protocol Number: CL-067-II-01 Start Date*: 2007-08-22
    Sponsor Name:CPDS BERMUDA, LTD.
    Full Title: OPEN-LABEL STUDY OF EFFICACY AND SAFETY OF 067 (TERBINAFINE IN TRANSFERSOME®) FOR THE TREATMENT OF ONYCHOMYCOSIS
    Medical condition: Bilateral onychomycosis of the hallux nail (great toe) with positive mycosis culture and KOH microscopy as per central laboratory, otherwise healthy according to physical examination
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-001269-18 Sponsor Protocol Number: VMT-VT-1161-CL-011 Start Date*: 2019-03-13
    Sponsor Name:Mycovia Pharmaceuticals, Inc
    Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VT-1161 Oral Capsules in the Treatment of Subjects with Recurrent Vulvovaginal Candidiasis
    Medical condition: Recurrent Vulvovaginal Candidiasis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10047784 Vulvovaginal candidiasis PT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: BG (Completed) PL (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2016-001242-25 Sponsor Protocol Number: BBT120126032001 Start Date*: 2017-02-07
    Sponsor Name:Blueberry Therapeutics Ltd.
    Full Title: An Early Phase Development, Partly Blinded, Positive and Vehicle Controlled, Randomized, Non-inferiority Investigation of the Pharmacokinetics, Safety and Efficacy of BB2603 Cutaneous Hand-Pump Spr...
    Medical condition: Onychomycosis and associated Tinea Pedis
    Disease: Version SOC Term Classification Code Term Level
    21.1 10021881 - Infections and infestations 10043873 Tinea pedis PT
    20.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003570-10 Sponsor Protocol Number: CSFO327N2303 Start Date*: 2007-03-02
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, open-label, active-controlled, multicenter, parallel group study to assess the efficacy, safety and tolerability of topical 10% terbinafine hydrogen chloride (HCl) formulation versus ...
    Medical condition: mild to moderate toenail onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed) FI (Completed) HU (Completed) ES (Completed) FR (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2014-001493-34 Sponsor Protocol Number: OM01 Start Date*: 2014-12-02
    Sponsor Name:photonamic GmbH & Co. KG
    Full Title: Evaluation of the suitability of PD P 506 A in the photodynamic therapy of Distal Subungual Onychomycosis (DSO) of the great toenail.
    Medical condition: Onychomycosis (OM) is a chronic fungal infection of the finger- or toenails and one of the commonest dermatological conditions. It accounts for one third of fungal skin infections and constitutes a...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005895-42 Sponsor Protocol Number: TLT-CLI-001 Start Date*: 2009-03-02
    Sponsor Name:TLT Medical Ltd.
    Full Title: A study to determine the safety and efficacy of a terbinafine topical formulation system in subjects with onychomycosis in laser treated toenails versus ciclopirox lacquer in intact toenails
    Medical condition: Distal/lateral Subungual onychomycosis (DSO) caused by dermatophytes
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-022622-32 Sponsor Protocol Number: MOB015-I Start Date*: 2010-11-11
    Sponsor Name:Moberg Derma AB
    Full Title: An open, multi-centre trial comparing the efficacy and safety of two different treatment regimens of topical MOB015 treatment of distal subungual onychomycosis (DSO)
    Medical condition: Distal subungual onychomycosis (DSO)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-013261-26 Sponsor Protocol Number: K101-I Start Date*: 2009-08-19
    Sponsor Name:Moberg Derma AB
    Full Title: A double-blind, randomized, multi-centre, placebo-controlled study of efficacy and safety of topical K101 in twelve months treatment of distal subungual onychomycosis (DSO)
    Medical condition: Distal subungual onychomycosis (DSO)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2019-002098-68 Sponsor Protocol Number: BBTAF202 Start Date*: 2020-02-04
    Sponsor Name:Blueberry Therapeutics Ltd
    Full Title: A Multi-Centre, International, Randomised, Vehicle Controlled, Parallel-Group, Double-Blinded Phase 2 Trial of BB2603 Topical Treatment in Subjects with Distal Subungual Onychomycosis (DSO) of the...
    Medical condition: Distal Subungual Onychomycosis (DSO) of the Toenail
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-000561-31 Sponsor Protocol Number: PM1331 Start Date*: 2015-06-15
    Sponsor Name:Polichem S.A.
    Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, VEHICLE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF P-3058 10% NAIL SOLUTION IN THE TREATMENT OF ONYCHOMYCOSIS
    Medical condition: Mild to moderate distal subungual Onychomycosis caused by Dermatophytes
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) LV (Completed) BG (Completed) SE (Completed) DE (Completed) SK (Completed) BE (Completed) PL (Completed) CZ (Completed) LT (Completed) GR (Completed) IS (Completed)
    Trial results: View results
    EudraCT Number: 2018-001270-26 Sponsor Protocol Number: VMT-VT-1161-CL-012 Start Date*: 2018-12-12
    Sponsor Name:Mycovia Pharmaceuticals, Inc
    Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VT-1161 Oral Capsules in the Treatment of Subjects with Recurrent Vulvovaginal Candidiasis
    Medical condition: Recurrent Vulvovaginal Candidiasis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10047784 Vulvovaginal candidiasis PT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: CZ (Completed) BE (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2006-001263-32 Sponsor Protocol Number: 241011BS Start Date*: 2006-07-21
    Sponsor Name:York Pharma GmbH
    Full Title: Phase III study to evaluate the anti-mycotic efficacy of a topical Abafungin formulation in patients with tinea pedis
    Medical condition: Patients with tinea pedis interdigitalis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) IS (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 16 16:21:42 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA